4//SEC Filing
Sandborn William J. 4
Accession 0001209191-23-045086
CIK 0001851194other
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 6:57 PM ET
Size
8.0 KB
Accession
0001209191-23-045086
Insider Transaction Report
Form 4
Sandborn William J.
See Remarks
Transactions
- Sale
Common Stock
2023-08-08$32.69/sh−2,086$68,181→ 25,602 total(indirect: By Spouse) - Sale
Common Stock
2023-08-08$33.12/sh−1,408$46,628→ 24,194 total(indirect: By Spouse)
Holdings
- 48,389
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on December 19, 2022.
- [F2]Represents the weighted average share price of an aggregate total of 2,086 shares sold in the price range of $32.0441 to $33.0225. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 1,408 shares sold in the price range of $33.055 to $33.37. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Ventyx Biosciences, Inc.
CIK 0001851194
Entity typeother
Related Parties
1- filerCIK 0001923805
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 6:57 PM ET
- Size
- 8.0 KB